PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 22, 2026Protein Science0 citations

Conformational dynamics in insulin receptor kinase reveal a type III allosteric pocket

View Full Paper
JVJyoti VermaHVHarish Vashisth

Key Points

  • The study aims to characterize a type III allosteric pocket in insulin receptor kinase to enhance understanding of selective kinase inhibition.
  • Conducted microsecond-scale molecular dynamics simulations on insulin receptor kinase structures.
  • Performed alchemical free energy calculations to analyze binding interactions.
  • Investigated conformational changes and thermodynamic properties of apo and inhibitor-bound IRK.
  • Identified critical residues involved in stabilizing the allosteric inhibitor.
  • Revealed a type III allosteric pocket acting as a back pocket in insulin receptor kinase.
  • Illustrated that the allosteric inhibitor adopts metastable conformations, influencing the kinase's inactive state.
  • Identified specific residues (M1051, F1054, V1060, F1128, E1043) as vital for stabilizing inhibitor binding.
  • Discovered a stable 'DFG-out' conformation in both bound and unbound states.

Abstract

Abstract Allosteric modulation is a promising strategy for selective kinase inhibition, yet structural insights into allosteric pockets remain limited across the human kinome. In this work, we present comprehensive characterization of a type III allosteric pocket in the insulin receptor kinase (IRK), integrating structural, conformational, and thermodynamic analyses. Specifically, we used microsecond‐scale atomistic molecular dynamics simulations in combination with alchemical free energy calculations to investigate apo and inhibitor‐bound IRK structures. Our findings indicate that the type III pocket is a “back pocket” in IRK, sandwiched between the N‐ and C‐terminal lobes. It features a hydrophobic cleft of aliphatic and aromatic non‐polar residues with a charge center for electrostatic interactions. Our results indicate that the allosteric inhibitor adopts metastable conformations of its 4‐carboxamide substituent, with the dominant pose stabilized by parallel stacking against the C‐helix and a persistent hydrogen bond with V1060. As a result, the C‐helix adopts an “out” conformation, promoting an inactive kinase state. Furthermore, MMPBSA calculations and alchemical transformations suggested M1051, F1054, V1060, F1128, and E1043 as critical residue hotspots, highlighting their roles in stabilizing the inhibitor. We observed a helical intermediate in the activation loop and a stable “DFG‐out” conformation in both apo and inhibitor bound conformations. Our results further identified M1051 as a key gatekeeper residue that maintains integrity of the C‐helix and regulates allosteric inhibitor binding. Our findings also revealed mechanistic details of inhibitor binding and the structural features of the type III pocket in IRK, aiding the design of selective allosteric modulators for receptor tyrosine kinases.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Verma et al. (2026) studied this question.

synapsesocial.com/papers/6971be6b642b1836717e3077https://doi.org/10.1002/pro.70455
Ask AI
Helpful
Bookmark
Share
View Full Paper